FATE THERAPEUTICS INC Stock Issued During Period, Shares, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- FATE THERAPEUTICS INC stock issued during period, shares, issued for services for the quarter ending 2016-12-31 was 0.00 shares.
- FATE THERAPEUTICS INC stock issued during period, shares, issued for services for the quarter ending 2016-09-30 was 0.00 shares.
- FATE THERAPEUTICS INC stock issued during period, shares, issued for services for the quarter ending 2016-06-30 was 0.00 shares.
- FATE THERAPEUTICS INC stock issued during period, shares, issued for services for the quarter ending 2016-03-31 was 37.64K shares, a 88.62% increase year-over-year.
- FATE THERAPEUTICS INC stock issued during period, shares, issued for services for fiscal 2016 was 37.64K shares, a 88.62% increase from fiscal 2015.
- FATE THERAPEUTICS INC stock issued during period, shares, issued for services for fiscal 2015 was 19.96K shares.
| Period end | Stock Issued During Period, Shares, Issued for Services 3 month | Stock Issued During Period, Shares, Issued for Services 12 month |
|---|---|---|
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 37.64K shares 10-K · filed 2017-03-16 |
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | 37.64K shares derived: sum of 4 quarters · filed 2016-11-07 |
| 2016-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | 37.64K shares derived: sum of 4 quarters · filed 2016-08-08 |
| 2016-03-31 | 37.64K shares 10-Q · filed 2016-05-09 | 37.64K shares derived: sum of 4 quarters · filed 2016-05-09 |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | 19.96K shares 10-K · filed 2016-03-03 |
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | |
| 2015-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | |
| 2015-03-31 | 19.96K shares 10-Q · filed 2015-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |